Tetherex Pharmaceuticals Overview
- Status
- Private
- Employees
- 6

- Latest Deal Type
- Series B
- Latest Deal Amount
- $50M

- Investors
- 7
Tetherex Pharmaceuticals General Information
Description
Developer of a medicinal drugs designed to treat thrombosis, inflammation and tumor metastasis. The company's drugs develop novel first-in-class therapeutics targeting cell adhesion proteins in thrombotic, inflammatory and oncologic diseases to work on the molecular mechanisms of cell adhesion and inflammation, enabling patients who suffer these afflictions enjoy descent and long lives.
Contact Information
- 840 Research Parkway
- Suite 516
- Oklahoma City, OK 73104
- United States
Tetherex Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
11. Later Stage VC (Series B) | 07-Mar-2018 | $50M | 000.00 | Completed | Clinical Trials - General | |
10. Debt - General | 09-Oct-2015 | 000 | 000.00 | Completed | Clinical Trials - General | |
9. Seed Round | 01-Jul-2015 | 000 | 000.00 | Completed | Clinical Trials - General | |
8. Later Stage VC (Series A) | 09-Feb-2015 | 00.000 | 000.00 | 000.00 | Completed | Clinical Trials - General |
7. Seed Round | 30-Oct-2014 | 000.00 | Completed | Clinical Trials - General | ||
6. Later Stage VC (Series A) | 17-Sep-2012 | 0000 | 000.00 | 000.00 | Completed | Clinical Trials - General |
5. Angel (individual) | 01-Apr-2010 | 0000 | 00.000 | Completed | Clinical Trials - General | |
4. Grant | 16-Jun-2009 | 00.00 | 00.00 | Completed | Clinical Trials - General | |
3. Later Stage VC | 16-Jun-2009 | $3.5M | $3.5M | Completed | Clinical Trials - General | |
2. Grant | 28-Apr-2009 | $300K | Completed | Clinical Trials - General |
Tetherex Pharmaceuticals Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | 0,000,000 | 00.000000 | 00.0 | 000 | 000 | 00 | 000 | 00.000 |
Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Tetherex Pharmaceuticals Comparisons
Industry
00000000
000 0000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialTetherex Pharmaceuticals Competitors (29)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Dendreon | Venture Capital-Backed | Seal Beach, CA | 000 | 00.00 | 000000000 - | 00.00 |
000 000000000000 | Venture Capital-Backed | Ann Arbor, MI | 00 | 000.00 | 00000000000 | 000.00 |
00000000 000000000 | Corporation | Norcross, GA | 0 | 000000000000 | ||
0000 0000 00000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000000 | 00000 |
000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
Tetherex Pharmaceuticals Executive Team (8)
Tetherex Pharmaceuticals Board Members (5)
Name | Representing | Role | Since |
---|---|---|---|
David Keiser | Self | Board Member | 000 0000 |
Philip Jones MD | Self | Board Member | 000 0000 |
Rodger McEver MD | Tetherex Pharmaceuticals | Co-Founder & Board Member | 000 0000 |
Scott Rollins Ph.D | Tetherex Pharmaceuticals | Chief Executive Officer & Chairman | 000 0000 |
Todd Foley | MPM Capital | Board Member | 000 0000 |
Tetherex Pharmaceuticals Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialTetherex Pharmaceuticals Investors (7)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Philip Jones | Angel (individual) | Minority | 000 0000 | 000000 0 | |
MPM Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
RAIN Source Capital | Angel Group | Minority | 000 0000 | 000000 0 | |
i2E | Venture Capital | Minority | 000 0000 | 000000 0 | |
Oklahoma Life Science Fund | Venture Capital | Minority | 000 0000 | 000000 0 |